Add BrightSurf on Google Email

Science News for March 6, 2005


St. John's wort amplifies effect of blood thinner Plavix

A small study found that St. John's wort amplifies the effect of blood thinner Plavix, potentially increasing the risk of bleeding among those who take both. The researchers plan to conduct further studies to confirm the finding and explore its implications for new drug development.

SourceMichigan Medicine - University of Michigan·DateMar 6, 2005

Study: Eye contact triggers threat signals in autistic children's brains

A UW-Madison study found that autistic children's amygdalas light up during non-threatening face gazing, stunting brain activity in the fusiform region. This challenges existing notions of facial processing in autism, suggesting a more complex relationship between social interaction and brain function.

SourceUniversity of Wisconsin-Madison·JournalNature Neuroscience·DateMar 6, 2005

Low socioeconomic status is a risk factor for mental illness

A study published by the American Psychological Association found that individuals with low socioeconomic status are at a higher risk of developing mental illness. The study suggests that economic stress, unemployment, and housing insecurity contribute to this increased risk.

SourceAmerican Psychological Association·JournalAmerican Journal of Orthopsychiatry·DateMar 6, 2005
Creality K1 Max 3D Printer

Creality K1 Max 3D Printer rapidly prototypes brackets, adapters, and fixtures for instruments and classroom demonstrations at large build volume.

Discovery clarifies role of peptide in biological clock

The study reveals that VIP peptide is essential for synchronizing the brain's biological clock, which regulates daily rhythms in behavior and physiology. Mice lacking VIP suffered from internal desynchrony, while adding VIP restored synchronicity.

SourceWashington University in St. Louis·JournalNature Neuroscience·DateMar 6, 2005

Three anti-platelet drugs used in combination are safe

In a randomized clinical trial, researchers found that combining three anti-platelet drugs did not increase the risk of bleeding, and treatment adherence was high. The combination of cilostazol, clopidogrel, and aspirin was tested in patients who had undergone successful angioplasty and stent implantation.

SourceEmory University Health Sciences Center·DateMar 6, 2005